Skip to main content

Table 4 Effect of bioscaffolds on hydroxyproline and hexosamine contents in animals

From: Design and evaluation of atorvastatin-loaded chitosan-hydroxyapatite composite bioscaffolds for wound-healing activity

Groups

Hydroxyproline content (mg/gm)

Hexosamine content (mg/gm)

Day 0

Day 11

Day 0

Day 11

Control

1.312 ± 0.035

0.828 ± 0.062

0.584 ± 0.050

0.123 ± 0.056

Hbc3

2.024 ± 0.069

4.581 ± 0.23 *

2.718 ± 0.63

3.664 ± 0.27 *

Hcc3

3.381 ± 0.151

11.257 ± 0.079 ***

0.767 ± 0.32

10.524 ± 0.203 ***

  1. Data are represented as mean ± S.D. (n = 6). Significantly different at *p < 0.05, **p < 0.01, and ***p < 0.001 in comparison to control group. Hbc3 containing 1.5 g of calcium chloride cross-linked with Hac1; Hcc3 containing 750 mg of atorvastatin loaded on Hbc3